| |
| Exchange: |
|
| Security
Type: |
|
| Shares
Out: |
10,260,000 |
| Market
Cap: |
60.43(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.72 - $8.23 |
|
| Level
I Sector: |
|
| Level
II Sector: |
|
| Level
III Sector: |
|
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Collplant Biotechnologies is a regenerative and aesthetic medicine company focused on three dimensional (3D) bioprinting of tissues and organs, and medical aesthetics. Co.'s products and product candidates are based on its recombinant human collagen (rhCollagen) that is produced with its proprietary plant based genetic engineering technology. Co.'s two rhCollagen-based family products lines are: CollPlant rhCollagen-based BioInk for use in the 3D printing of tissues and organs; and aesthetic medicine product line including a dermal filler and breast implants. Co. also markets two of its products in Europe: VergenixSTR, a soft tissue matrix, and VergenixFG, a wound healing flowable gel.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
0.53 (9.89%) 
